| COCRYSTAL PHARMA NEW O.N. |
| USA |
| Gesundheit |
| US19188J4094 / A3DWYX |
| 8CC (Frankfurt) / COCP (NASDAQ) |
| FRA:8CC, ETR:8CC, 8CC:GR, NASDAQ:COCP |
| - |
| https://www.cocrystalphar.. |
|
Cocrystal Pharma Inc. is a biotechnology company that specializes in developing antiviral therapeutics for the treatment of serious and chronic viral infections. The company's primary function is to innovate in the field of antiviral drug discovery u..
>Volltext.. |
| 11.92 Mio. EUR |
| 6.66 Mio. EUR |
| - |
| -8.37 Mio. EUR |
| -8.36 Mio. EUR |
| -0.81 EUR |
| 1.37 Mio. EUR |
| 6.75 Mio. EUR |
| -8.08 Mio. EUR |
| 5.13 |
| - |
| 50.93% |
| - |
| - |
| - |
| - |
| COCRYSTAL |
| 02.04.26 |
|